News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Thomas Dolca
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Disposed/sold 13,300 shares
@ $0
Disposed/sold 23,522 options to buy
@ $14.77, valued at
$347.4k
Disposed/sold 5,948 options to buy
@ $16.81, valued at
$100k
Disposed/sold 13,300 options to buy
@ $13.88, valued at
$184.6k
|
|
| 08/03/2023 |
4
| Thomas Dolca (Director) has filed a Form 4 on Allakos Inc.|
Txns:
| Granted 154,786 options to buy
@ $5.55, valued at
$859.1k
|
|
| 05/31/2023 |
4
| Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
| 09/06/2022 |
4
| Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Bought 9,700 shares
@ $21.22, valued at
$205.8k
Bought 300 shares
@ $21.2, valued at
$6.4k
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Thomas Dolca (Director) has filed a Form 4 on CHINOOK THERAPEUTICS, INC.|
Txns:
| Granted 5,948 options to buy
@ $16.81, valued at
$100k
|
|
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2020 |
4
| Thomas Dolca (Director) has filed a Form 4 on ADURO BIOTECH, INC.|
Txns:
| Granted 23,522 options to buy
@ $14.77, valued at
$347.4k
|
|
| 09/28/2020 |
4
| Thomas Dolca (Chief Medical Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Unknown transaction of 2,207 shares
@ $100, valued at
$220.7k
Disposed/sold 168,057 options to buy
@ $23.77, valued at
$4M
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 08/20/2020 |
4
| Thomas Dolca (Chief Medical Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 15,000 shares
@ $100, valued at
$1.5M
Exercised 15,000 options to buy
@ $23.77, valued at
$356.6k
|
|
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Thomas Dolca (Chief Medical Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2019 |
4
| Thomas Dolca (Chief Medical Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 60,000 options to buy
@ $35.42, valued at
$2.1M
|
|
|
|